Insulin Resistance May Increase Risk for Cardiovascular and Metabolic Diseases
A study was conducted to determine the relationship among insulin resistance, mortality, and cardiovascular disease in patients from 5 continents.
Diagnosis & Disease Information
We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Can SGLT2 and GLP1 Agents Be Cost-Effective First-Line Treatments for Diabetes?
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
Maintaining Weight Loss After Intensive Lifestyle Intervention and Lower CV Risk in Type 2 Diabetes
Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Excessive Body Weight Change Linked to Increased Risk of Cardiovascular Events in Type 2 Diabetes
Investigators sought to determine if an association existed between weight change and major cardiovascular outcomes among patients with type 2 diabetes.
- Loading...
Loading...
Next post in Endocrinology
Loading... 
Loading...